MTOR and neoplasm: In addition, we experimentally observed that –as predicted by this hypothetic mechanistic relationship– the loss of function of MLL2 in cell lines derived from tissues in which MLL2 drives tumorigenesis renders tumor cells more sensitive to mTOR inhibitors.